C. Herrero

发表

M. Lecha, J. Vilaplana, E. Botey, 2002, Contact dermatitis.

Membrane attack complex deposits in cutaneous lesions of dermatomyositis.

J. Grau, C. Herrero, M. Cid, 1995, Archives of dermatology.

Comparative Analysis of Acute Cutaneous Lupus Erythematosus with Subacute and Chronic Cutaneous Lupus Erythematosus: Clinical and Immunological Study of 308 Patients

M. García-Carrasco, R. Cervera, C. Herrero, 2016 .

Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender

M. García-Carrasco, M. Ramos-Casals, C. Herrero, 2010, Clinical and experimental dermatology.

Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients

M. García-Carrasco, M. Ramos-Casals, C. Herrero, 2010, The British journal of dermatology.

Cutaneous Vasculitis in Primary Sjögren Syndrome: Classification and Clinical Significance of 52 Patients

J. Anaya, M. García-Carrasco, M. Ramos-Casals, 2004, Medicine.

Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.

M. García-Carrasco, R. Cervera, M. Ramos-Casals, 2004, Seminars in arthritis and rheumatism.

Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor

E. Poch, S. Segura, C. Herrero, 2007, The British journal of dermatology.

Porphyria cutanea tarda and glucose metabolism alterations: reply from authors

C. Herrero, C. Muñoz-Santos, A. Guilabert, 2011 .

The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long‐term follow‐up cohort

C. Herrero, C. Muñoz-Santos, J. To-Figueras, 2011, The British journal of dermatology.

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

J. Miro, P. Muñoz, C. Herrero, 2019, Annals of Clinical Microbiology and Antimicrobials.

Atypical pemphigus: discordance between clinicopathological findings and the antigenic profile in four cases

C. Herrero, J. Herrero‐Gonzalez, J. Mascaró, 2006, Journal of cutaneous pathology.

Complement Activation Products (C3a and C5b-9) as Markers of Activity of Dermatomyositis. Comparison With Tradicional Laboratory Markers

J. M. Porcel, R. Martí, J. Grau, 2007 .

Immunopathologic study of skin lesions in dermatomyositis.

M. Lecha, C. Herrero, M. Cid, 1991, Journal of the American Academy of Dermatology.

Cell adhesion molecule expression in cutaneous lesions of dermatomyositis.

C. Herrero, M. Cid, J. Mascaró, 1996, Acta dermato-venereologica.

Increased serum hepcidin levels in patients with porphyria cutanea tarda

R. Deulofeu, C. Herrero, M. Westerman, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Cyclosporine A as first choice therapy for dermatomyositis.

J. Fernandez-Solà, J. Grau, C. Herrero, 1994, The Journal of rheumatology.

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection

C. Herrero, A. Toll, M. Bruguera, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda.

C. Herrero, A. Toll, R. Celis, 2006, Acta dermato-venereologica.

Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

C. Herrero, J. Rodés, M. Bruguera, 1993, The Lancet.

Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.

Ò. Miró, J. Grau, C. Herrero, 1996, The Journal of rheumatology.

New reasons for an archaic treatment: phlebotomy in sporadic porphyria cutanea tarda.

C. Herrero, J. Mascaró, 2003, Archives of dermatology.

Analysis of the outcome of idiopathic inflammatory myopathies with particular emphasis on muscle capillary damage.

J. Grau, C. Herrero, J. Casademont, 1993, Scandinavian journal of rheumatology.

OVELTIES IN DERMATOLOGY ew Developments in Erythropoietic Porphyrias

C. Herrero, .. Darwich, 2017 .

New developments in erythropoietic porphyrias.

C. Herrero, E. Darwich, 2013, Actas dermo-sifiliograficas.

Excretion of hexachlorobenzene and metabolites in feces in a highly exposed human population.

J. Sunyer, J. Grimalt, C. Herrero, 2000, Environmental health perspectives.

Clinical and laboratorv studies Immunopathologic study of skin lesions in dermatomyositis

M. Lecha, C. Herrero, M. Cid, 1991 .

Acquired immunodeficiency syndrome in a patient affected by hereditary coproporphyria: safety of zidovudine treatment.

A. Azon, C. Herrero, J. Miró, 1990, Archives of dermatology.

New‐onset psoriasis in a patient treated with interferon beta‐1a

C. Herrero, I. López-Lerma, P. Iranzo, 2009, The British journal of dermatology.

[Systemic lupus erythematosus: a clinical and immunological study of 300 patients].

R. Cervera, J. Font, C. Herrero, 1993, Medicina clinica.

Streptococcal myositis as a complication of juvenile dermatomyositis

Felipe García, J. Grau, C. Herrero, 1991, Neuromuscular Disorders.

Morphoea in three siblings

M. Lecha, C. Herrero, J. Palou, 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

Familial and Sporadic Porphyria Cutanea Tarda: Clinical and Biochemical Features and Risk Factors in 152 Patients

C. Badenas, C. Herrero, C. Muñoz-Santos, 2010, Medicine.

Management of patients with porphyria cutanea tarda

M. Lecha, C. Herrero, 1998, Photodermatology, photoimmunology & photomedicine.

Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases.

M. Lecha, J. Font, C. Herrero, 1988, Journal of the American Academy of Dermatology.

Bullous pemphigoid associated with mantle cell lymphoma.

E. Campo, C. Herrero, J. Mascaró, 2004, Archives of dermatology.

High Mortality Related with Staphylococcus aureus Bacteremia After Liver Transplantation

M. L. de la Mata, M. Mata, C. Herrero, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Multicentric reticulohistiocytosis with elevated cytokine serum levels

A. Bennássar, C. Herrero, J. Mascaró-Galy, 2011, The Journal of dermatology.

Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene

Xavier Basagaña, Carmen Herrero, Jordi Sunyer, 2002, Environmental health : a global access science source.

Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene.

X. Basagaña, J. Sunyer, J. Grimalt, 2002, Environmental health perspectives.

Urinary porphyrin excretion in a human population highly exposed to hexachlorobenzene.

J. Sunyer, J. Grimalt, R. Deulofeu, 1999, Archives of dermatology.

Papulonecrotic tuberculide in a human immunodeficiency virus type 1‐seropositive patient

C. Herrero, M. Alsina, A. Toll, 2000, British Journal of Dermatology.

Nail alterations in systemic amyloidosis: report of one case, with histologic study.

A. Vilalta, C. Herrero, J. Mascaró, 1988, Journal of the American Academy of Dermatology.

Systemic Candidiasis in Heroin Abusers Cutaneous Findings

J. Miro, C. Herrero, I. Bielsa, 1987, International journal of dermatology.

[Bronchiolitis obliterans associated with paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome].

E. Campo, C. Herrero, A. Xaubet, 2004, Archivos de bronconeumologia.

Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.

C. Herrero, M. Baradad, A. Llambrich, 2005, Acta dermato-venereologica.

Pyoderma Vegetans Associated with Severe Psoriatic Arthritis: Good Response to Etanercept

C. Carrera, J. Palou, C. Herrero, 2006, Dermatology.

Correlation of immunological profile with phenotype and disease outcome in pemphigus.

C. Herrero, D. Benítez, J. Herrero‐Gonzalez, 2010, Acta dermato-venereologica.

Autoantibodies from patients with BSLE inducing recruitment of leukocytes to the dermoepidermal junction and subepidermal splits in cryosections of human skin.

D. Zillikens, C. Herrero, C. Sitaru, 2006, Archives of dermatology.

Sclerodermiform linear lupus erythematosus: A distinct entity or coexistence of two autoimmune diseases?

C. Herrero, J. Ferrando, J. Mascaró, 2008, Journal of the American Academy of Dermatology.

Immunogenetic findings in cutaneous lupus erythematosus.

J. Font, C. Herrero, M. Ingelmo, 1991, Journal of the American Academy of Dermatology.

Uncommon cutaneous manifestations of lupus erythematosus

C. Herrero, J. Mascaró, G. Hausmann, 1997, Lupus.

Histopathologic findings in cutaneous lupus erythematosus.

C. Herrero, I. Bielsa, A. Cobos, 1994, Archives of dermatology.

Subacute cutaneous lupus Clinicopathologic findings erythematosus: in thirteen cases

M. Lecha, J. Font, C. Herrero, 1988 .

Lupus erythematosus and toxic epidermal necrolysis.

J. Font, C. Herrero, I. Bielsa, 1987, Journal of the American Academy of Dermatology.

Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents

C. Herrero, J. Mascaró, A. Llambrich, 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.

S. Segura, C. Herrero, M. Alsina, 2007, Journal of the American Academy of Dermatology.

Acquired ichthyosis in a patient with systemic lupus erythematosus.

X. Bosch, J. Font, C. Herrero, 1990, Archives of dermatology.

[Cicatricial pemphigoid of Brunsting Perry].

M. Lecha, C. Herrero, T. Castel, 1979, Actas dermo-sifiliograficas.

Gold: an old drug still working in refractory pemphigus

S. Segura, C. Herrero, M. Alsina, 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

Successful Treatment of Congenital Erythropoietic Porphyria Using Matched Unrelated Hematopoietic Stem Cell Transplantation

C. Badenas, S. Arias-Santiago, C. Herrero, 2013, Pediatric dermatology.

HEPATOERYTHROPOIETIC PORPHYRIA: A NEW UROPORPHYRINOGEN DECARBOXYLASE DEFECT OR HOMOZYGOUS PORPHYRIA CUTANEA TARDA?

G. Elder, C. Herrero, S. G. Smith, 1981, The Lancet.

Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.

C. Badenas, M. Lecha, C. Herrero, 2007, Blood cells, molecules & diseases.

Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection

S. Puig, C. Badenas, M. Milá, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria.

Ó. Pozo, J. Marcos, C. Herrero, 2013, Clinical biochemistry.

Usefulness of Chromatographic Analysis of Fecal Porphyrins in the Diagnosis of Porphyrias

M. Lecha, C. Herrero, J. Mascaró, 1990, The Journal of dermatology.

Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene

C. Badenas, J. Phillips, C. Herrero, 2011, The British journal of dermatology.

Microscopic abnormalities in the liver of two patients with Porphyria variegate

M. Lecha, C. Herrero, M. Bruguera, 1985, Journal of cutaneous pathology.

Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population.

J. Sunyer, J. Grimalt, C. Herrero, 1997, Environmental health perspectives.

Erythema multiforme presenting as cholestatic acute hepatitis caused by Epstein‐Barr virus

C. Herrero, M. Alsina, P. Iranzo, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients.

M. L. de la Mata, G. Miño, M. Mata, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.

C. Beaumont, C. Ged, S. Ducamp, 2011, Blood.

Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus.

C. Ged, M. Méndez, H. de Verneuil, 2002, Archives of dermatology.

Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation

C. Badenas, M. Milá, M. Lecha, 2006, Journal of Inherited Metabolic Disease.

[Acute intermittent porphyria: Long-term follow up of 35 patients].

C. Badenas, C. Herrero, P. Aguilera, 2015, Medicina clinica.

Role of two nutritional hepatic markers (insulin‐like growth factor 1 and transthyretin) in the clinical assessment and follow‐up of acute intermittent porphyria patients

H. Puy, R. Casamitjana, C. Herrero, 2009, Journal of internal medicine.

Brainstem dysfunction in variegate porphyria

J. Valls-Solé, T. Serranová, C. Herrero, 2012, Muscle & nerve.

Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.

C. Badenas, C. Herrero, J. To-Figueras, 2010, Archives of dermatology.

Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives

C. Badenas, C. Herrero, J. To-Figueras, 2009, Clinical genetics.

Childhood‐onset mild cutaneous porphyria with compound heterozygotic mutations in the uroporphyrinogen decarboxylase gene

G. Emri, I. Horkay, C. Badenas, 2008, Clinical and experimental dermatology.

A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.

G. Elder, M. Lecha, A. Roberts, 1995, The Journal of investigative dermatology.

Congenital erythropoietic porphyria and Parkinson's disease: clinical association in a patient with a long-term follow-up.

C. Herrero, J. To-Figueras, A. Guilabert, 2011, European journal of dermatology : EJD.

Hepatoerythropoietic porphyria: neuroimaging findings.

J. Mercader, C. Herrero, J. Berenguer, 1997, AJNR. American journal of neuroradiology.

[Hepato-erythrocytic porphyria. A new type of porphyria].

A. Giménez, C. Herrero, J. Ferrando, 1975, Annales de dermatologie et de syphiligraphie.

Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.

C. Badenas, M. Méndez, M. Lecha, 2007, Archives of dermatology.

Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria.

X. Schneider-Yin, J. Deybach, L. Gouya, 1998, The Journal of investigative dermatology.

[Liver disease in erythropoietic protoporphyria].

C. Herrero, M. Bruguera, 2005, Gastroenterologia y hepatologia.

Systemic lupus erythematosus in a patient with partial lipodystrophy.

X. Bosch, J. Font, C. Herrero, 1990, Journal of the American Academy of Dermatology.

[Complement activation products (C3a and C5b-9) as markers of activity of dermatomyositis. Comparison with usual biochemical parameters].

R. Martí, J. Grau, C. Herrero, 2007, Actas dermo-sifiliograficas.

Diagnosis and treatment of the hepatic porphyrias

M. Lecha, C. Herrero, D. Ozalla, 2003, Dermatologic therapy.

Trigeminal sensory‐neuropathy in systemic sclerosis

C. Herrero, J. Mascaró, A. Vicente, 1991, Clinical and experimental dermatology.

Association between serum concentrations of hexachlorobenzene and polychlorobiphenyls with thyroid hormone and liver enzymes in a sample of the general population

J. Sunyer, J. Grimalt, C. Herrero, 2001, Occupational and environmental medicine.

Dermoscopic description of a patient with thrombocythemia and factor V Leiden mutation‐associated Degos’ disease

J. Malvehy, S. Puig, C. Herrero, 2011, International journal of dermatology.

Mycosis Fungoides with Oral Involvement

R. Martí, C. Herrero, T. Estrach, 1991, International journal of dermatology.

Health effects of chronic high exposure to hexachlorobenzene in a general population sample.

M. Kogevinas, J. Sunyer, J. Grimalt, 1999, Archives of environmental health.

Urinary Porphyrin Excretion in Children is Associated with Exposure to Organochlorine Compounds

J. Sunyer, M. Álvarez-Pedrerol, J. Grimalt, 2008, Environmental health perspectives.

[Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors].

Ò. Miró, M. Laguno, J. Grau, 1999, Medicina clinica.

Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy

M. Lecha, C. Herrero, A. Toll, 1998, Lupus.

T-cell population of primary and secondary cutaneous B-cell lymphomas does not express the cutaneous lymphocyte-associated antigen (CLA)

R. Martí, C. Herrero, M. Cid, 1997, Archives of Dermatological Research.

Biochemical and genetic characterization of four cases of hereditary coproporphyria in Spain.

C. Badenas, M. Milá, C. Herrero, 2005, Molecular genetics and metabolism.

[Early forms of porphyria cutanea tarda. Apropos of 2 cases with a study of familial enzymatic deficiency and definition of the mode of genetic transmission].

G. Elder, M. Lecha, C. Herrero, 1984, Annales de dermatologie et de venereologie.

Thin layer chromatography and counter‐current analysis in porphyrias

C. Herrero, R. V. Belcher, S. Smith, 1975, The British journal of dermatology.

Scleromyxoedema treated with autologous stem cell transplantation

C. Herrero, J. Bladé, I. López-Lerma, 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene

X. Basagaña, J. Sunyer, J. Grimalt, 2002, Environmental health : a global access science source.

Correlation of immunological profile with phenotype and disease outcome in pemphigus.

C. Herrero, D. Benítez, J. Mascaró, 2010, Acta dermato-venereologica.

[Bullous pemphigoid and multiple sclerosis].

S. Puig, D. Tomasini, C. Herrero, 1991, Annales de dermatologie et de venereologie.

EXPRESSION OF THE CUTANEOUS LYMPHOCYTE ANTIGEN (CLA/HECA-452) IN THE INFLAMMATORY INFLTRATES OF SKIN AND MUSCLE LESIONS OF DERMATOMYOSITIS. A DOUBLE IMMUNOFLUORESCENCE STUDY.

R. Martí, J. Grau, M. Lecha, 1998 .